These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6234161)

  • 1. Immune responsiveness and phagocytic activity of macrophages in streptozotocin (SZ)-induced diabetic mice.
    Nakano K; Yoshida T; Kondo M; Muramatsu S
    Endocrinol Jpn; 1984 Feb; 31(1):15-22. PubMed ID: 6234161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic features of mice with streptozotocin-induced diabetes: depression of their immune responses to sheep red blood cells.
    Ishibashi T; Kitahara Y; Harada Y; Harada S; Takamoto M; Ishibashi T
    Diabetes; 1980 Jul; 29(7):516-23. PubMed ID: 7380115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of increase in macrophage Ia expression on subsequent immune response in vivo.
    Koga T; Mitsuyama M; Watanabe Y; Yamada A; Yoshikai Y; Nomoto K
    J Clin Lab Immunol; 1986 May; 20(1):29-35. PubMed ID: 3090269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice.
    Gaulton GN; Schwartz JL; Eardley DD
    Diabetologia; 1985 Oct; 28(10):769-75. PubMed ID: 2933286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressed immunological defence mechanisms in mice with experimentally induced diabetes.
    Saiki O; Negoro S; Tsuyuguchi I; Yamamura Y
    Infect Immun; 1980 Apr; 28(1):127-31. PubMed ID: 6966615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products.
    Liu BF; Miyata S; Kojima H; Uriuhara A; Kusunoki H; Suzuki K; Kasuga M
    Diabetes; 1999 Oct; 48(10):2074-82. PubMed ID: 10512376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RES hyperphagocytosis by rats with streptozotocin-induced diabetes mellitus.
    Cornell RP
    Am J Physiol; 1981 Mar; 240(3):G225-31. PubMed ID: 6452065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nitric oxide generation: normalization of in vitro insulin secretion in mice with multiple low-dose streptozotocin and in mice injected with mononuclear splenocytes from diabetic syngeneic donors.
    Karabatas LM; Fabiano de Bruno L; Pastorale CF; Cullen C; Basabe JC
    Metabolism; 1996 Aug; 45(8):940-6. PubMed ID: 8769348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.
    McEvoy RC; Andersson J; Sandler S; Hellerström C
    J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Fc receptor function of macrophages from streptozotocin-induced diabetic rats.
    Abrass CK; Hori M
    J Immunol; 1984 Sep; 133(3):1307-12. PubMed ID: 6235285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice.
    Maruyama T; Takei I; Yanagawa T; Takahashi T; Asaba Y; Kataoka K; Ishii T
    Diabetes Res; 1988 Feb; 7(2):93-6. PubMed ID: 3293880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired phagocytosis by alveolar macrophages from diabetic rats is related to the deficient coupling of LTs to the Fc gamma R signaling cascade.
    Ferracini M; Martins JO; Campos MR; Anger DB; Jancar S
    Mol Immunol; 2010 Jul; 47(11-12):1974-80. PubMed ID: 20510456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
    Leiter EH; Beamer WG; Shultz LD
    Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age.
    Riley WJ; McConnell TJ; Maclaren NK; McLaughlin JV; Taylor G
    Diabetes; 1981 Sep; 30(9):718-23. PubMed ID: 6455320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical permethrin exposure inhibits antibody production and macrophage function in C57Bl/6N mice.
    Punareewattana K; Smith BJ; Blaylock BL; Longstreth J; Snodgrass HL; Gogal RM; Prater RM; Holladay SD
    Food Chem Toxicol; 2001 Feb; 39(2):133-9. PubMed ID: 11267706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.
    Pour PM; Kazakoff K; Carlson K
    Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin on naturally occurring gingivitis rats with diabetes.
    Hayashi A; Shinohara M; Ohura K
    J Osaka Dent Univ; 1999 Apr; 33(1):1-7. PubMed ID: 10863470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptozotocin-induced liver damage in mice.
    Laguens RP; Candela S; Hernández RE; Gagliardino JJ
    Horm Metab Res; 1980 May; 12(5):197-201. PubMed ID: 6446516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired wound healing in streptozotocin diabetes. Prevention by supplemental vitamin A.
    Seifter E; Rettura G; Padawer J; Stratford F; Kambosos D; Levenson SM
    Ann Surg; 1981 Jul; 194(1):42-50. PubMed ID: 6454399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A re-evaluation of the role of macrophages in carrageenan-induced immunosuppression.
    Rumjanek VM; Watson SR; Sljivić VS
    Immunology; 1977 Sep; 33(3):423-32. PubMed ID: 332622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.